<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04339725</url>
  </required_header>
  <id_info>
    <org_study_id>STOOL</org_study_id>
    <nct_id>NCT04339725</nct_id>
  </id_info>
  <brief_title>Gut Microbiota Metagenomics for Chronic Liver Disease</brief_title>
  <official_title>Research Based on Gut Microbiota Metagenomics for Prevention of Chronic Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chuncheon Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chuncheon Sacred Heart Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gut microbiota modulation has effect on chronic liver disease
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic liver disease has been known as a disease of the liver which lasts over a period of
      6-month. It consists of inflammation, hepatitis, cirrhosis, hepatocellular carcinoma.

      Gut microbiota plays an important roles in the chronic liver disease. It can suppress the
      progression of the liver disease by moulation gut microbiota.

      The investigators are still evaluating the effect of gut microbiota on the liver disease.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal DNA</measure>
    <time_frame>10 years</time_frame>
    <description>Compare the species and proportions of the gut microbiome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Liver enzyme</measure>
    <time_frame>10 years</time_frame>
    <description>Compare the liver enzyme level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BMI</measure>
    <time_frame>10 years</time_frame>
    <description>Compare the body mass index</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3240</enrollment>
  <condition>Liver Disease Chronic</condition>
  <arm_group>
    <arm_group_label>Fecal DNA</arm_group_label>
    <description>Extraction fecal DNA and compare disease group to normal group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>DNA extraction</intervention_name>
    <description>Extraction fecal DNA and compare disease group to normal group</description>
    <arm_group_label>Fecal DNA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        3240 of population stool were collected. All of them are agree to provide it to
        investigation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 19+

          -  Normal : AST or ALT level &lt; 50IU/L, BMI &lt; 25

          -  Liver disease : AST or ATL level ≥ 50IU/L, BMI ≥ 25

          -  Patients hospitalized with chronic liver disease (viral hepatitis, alcoholic liver
             disease, non-alcoholic liver disease, cirrhosis, liver cancer)

        Exclusion Criteria:

          -  Normal : AST or ATL level ≥ 50IU/L, BMI ≥ 25

          -  Liver disease : AST or ALT level &lt; 50IU/L, BMI &lt; 25

          -  If the patient refuses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>31 Years</minimum_age>
    <maximum_age>82 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital</name>
      <address>
        <city>Chuncheon</city>
        <zip>200-704</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chuncheon Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Ki Tae Suk</investigator_full_name>
    <investigator_title>Proffesor</investigator_title>
  </responsible_party>
  <keyword>Liver</keyword>
  <keyword>Fecal</keyword>
  <keyword>Gut microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

